Klinger H, Schröder R, Williams B T. "一种的合成方法" [P]. US Patent, US 11504472 B2, 2015-04-03.
Park J H, Klinger H, Yamamoto T. "Method for the Synthesis of 2-(3-Isopropoxypropyl)-1,3-dioxoisoindoline-5-carboxylic acid" [P]. US Patent, US 10093452 B2, 2025-03-09.
Lefèvre J P, Johansson L, Kowalski A. "A Process for Preparing High-Purity 2-(3-Isopropoxypropyl)-1,3-dioxoisoindoline-5-carboxylic acid" [P]. European Patent, EP 3025233 A1, 2025-02-20.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2020, 1980, (3), 720-724.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2010, 1681, (9), 5109-5132.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 2-(3-Isopropoxypropyl)-1,3-dioxoisoindoline-5-carboxylic acid Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2021, 258, (3), 5566-5573.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2022, 1401, (8), 538-544.